End-of-day quote
Other stock markets
|
||
- EUR | - |
03-13 | Almirall Signs License Deal with Eloxx Pharmaceuticals for Skin Diseases Treatment | MT |
02-19 | Global markets live: Apple, Nintendo, Super Micro Computer, Currys, ABB... |
Sales 2024 * | 971M 1.05B 1.43B | Sales 2025 * | 1.07B 1.15B 1.58B | Capitalization | 1.82B 1.96B 2.68B |
---|---|---|---|---|---|
Net income 2024 * | 25M 26.9M 36.82M | Net income 2025 * | 62M 66.72M 91.3M | EV / Sales 2024 * | 1.79 x |
Net cash position 2024 * | 81.01M 87.17M 119M | Net cash position 2025 * | 115M 123M 169M | EV / Sales 2025 * | 1.59 x |
P/E ratio 2024 * |
84.4
x | P/E ratio 2025 * |
30.3
x | Employees | - |
Yield 2024 * |
2.15% | Yield 2025 * |
2.18% | Free-Float | 34.78% |
Latest transcript on Almirall SA
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 14-07-24 | |
Director of Finance/CFO | 54 | 19-11-10 | |
Karl Ziegelbauer
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 81 | 07-05-28 | |
Seth J. Orlow
BRD | Director/Board Member | - | 15-12-31 |
Eva-Lotta Allan
BRD | Director/Board Member | 65 | 20-06-30 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |